A second buyer has made an offer to buy the DNA sequencing company Singular Genomics Systems, potentially ...
A few months after a key label expansion, AstraZeneca’s asthma treatment Fasenra has received FDA approval to treat a rare ...
Roivant is once again reaping the benefits of its bespoke business model. This time, it's selling Dermavant to Organon for up ...
Insilico Medicine reported Phase 2a results for its lead program, saying the study achieved its primary endpoint of safety ...
Keytruda is already approved in more than 40 different oncology indications, but its latest label expansion is a first for ...
Novo Nordisk is doubling down on its investment in genetic medicine-based biotechs, inking a new collaboration with a lipid ...
Just hours after the US Federal Reserve announced the first interest rate cut in four years, respiratory biotech Upstream Bio ...
A startup in Brazil that lets people easily buy medicine online by combining a consumer-friendly experience with prescription ...
Sens. Marco Rubio (R-FL) and Angus King (I-ME) have told the FDA that “considerable work” needs to be done to address ...
A promising new approach that could slow, stop or prevent nerves from dying may get its first test in patients next year.
Merck and Daiichi Sankyo have passed a Phase 3 with the lead antibody-drug conjugate from the megadeal they disclosed at last ...
One of this weekend’s sleeper data presentations at Europe’s biggest oncology conference puts Pfizer in a leading position in ...